Door 16! 🎁
Behind Door 16, we find Novo Nordisk and Allianz in the CB European Quality Fund, and Thermo Fisher Scientific in the CB Save Earth Fund.
Novo Nordisk – the Danish pharmaceutical giant.
⭐ Insulin: The company is a global leader in diabetes care, holding approximately half of the global insulin market.
⭐ Weight management: Novo Nordisk owns and has developed leading brands in diabetes and weight management, such as Ozempic and Wegovy.
🌱 The company works in line with the UN Sustainable Development Goals and has set SBTi-verified CO₂ reduction targets.
Allianz – a German insurance and asset management giant.
⭐ Market leader: Allianz is a global leader in travel insurance and in insurance distributed through strategic partnerships, for example with travel companies and banks.
⭐ Global scale: The company is one of the world’s largest insurance and asset management groups, operating in more than 70 countries, with approximately 156,000 employees and trillions of euros in assets under management (AUM).
🌱 Allianz places particular focus on three of the 17 UN Sustainable Development Goals: Goals 8, 13, and 17.
Thermo Fisher Scientific – a global U.S.-based leader in scientific services.
⭐ Water analysis: Thermo Fisher offers a broad portfolio of analytical instruments and systems for water analysis, including its well-known Orion and AquaSensors portfolios.
⭐ Regulatory compliance: Its solutions are used by water utilities, environmental laboratories, and public authorities to meet requirements such as the EU Drinking Water Directive and EPA standards.
🌱 The company works in line with the UN Sustainable Development Goals, has set SBTi-verified CO₂ reduction targets, and generates EU Taxonomy–aligned revenues.
This message should not be considered financial advice, but marketing communication. Please note that all investments involve risk. The value of fund units may increase or decrease, and there is always a risk of loss. Past performance is not a guarantee of future results. Please note that the companies mentioned were included in the respective fund portfolios as of 16 December. In theory, the companies may have exited the portfolios by the time this content is published.